Skip to main content

Table 2 Drugs targeting HIF/HIF mediated metabolic enzymes

From: Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy

Drug Target Tumor Ref
Atorvastatin HIF-1α Burkitt’s Lymphoma [115]
Oxaliplatin HIF-1α Colorectal cancer [116]
Tamoxifen HIF-1α Breast cancer [109]
Trichostatin A HIF-1α Cervical cancer [117]
Diacetoxyscirpenol HIF-1α Liver cancer [118]
Metformin HIF-1α Breast cancer [119]
Metformin HIF-1α/GLUT, HK2, PKM, LDH Cervical cancer [120]
Ginsenoside Compound K HIF-1α/PDK1 Lung cancer [121]
Dovitinib HIF-1α/GLUT Lung cancer [112]
Metformin HIF-1α/PDH Oral cancer [110]
Cetuximab HIF-1α/LDHA Head and neck cancer [111]
Troxacitabine HIF-1α/PGK Lung cancer [122]